| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $212,658 | +4,599 | +2% | $46.24 | 234,599 | 17 Nov 2023 | Ordinary Shares | 4,599 | $46.24 | Direct | F1, F2 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $279,250 | +3,999 | +2% | $69.83 | 203,999 | 17 Nov 2023 | Ordinary Shares | 3,999 | $69.83 | Direct | F1, F2 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $189,808 | +5,999 | +2% | $31.64 | 305,999 | 17 Nov 2023 | Ordinary Shares | 5,999 | $31.64 | Direct | F1, F2 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $213,946 | +3,999 | +2% | $53.50 | 203,999 | 17 Nov 2023 | Ordinary Shares | 3,999 | $53.50 | Direct | F1, F2 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $388,980 | +5,899 | +2% | $65.94 | 300,899 | 17 Nov 2023 | Ordinary Shares | 5,899 | $65.94 | Direct | F1, F2 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $77,239 | +2,419 | +2% | $31.93 | 123,419 | 17 Nov 2023 | Ordinary Shares | 2,419 | $31.93 | Direct | F1, F2 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $244,073 | +7,644 | +2% | $31.93 | 389,844 | 17 Nov 2023 | Ordinary Shares | 7,644 | $31.93 | Direct | F1, F3 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $143,575 | +7,168 | +2% | $20.03 | 365,634 | 17 Nov 2023 | Ordinary Shares | 7,168 | $20.03 | Direct | F1, F4 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $132,344 | +6,843 | +2% | $19.34 | 349,030 | 17 Nov 2023 | Ordinary Shares | 6,843 | $19.34 | Direct | F1, F5 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $147,048 | +5,980 | +2% | $24.59 | 305,024 | 17 Nov 2023 | Ordinary Shares | 5,980 | $24.59 | Direct | F1, F6 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Other | $152,794 | +5,697 | +2% | $26.82 | 290,570 | 17 Nov 2023 | Ordinary Shares | 5,697 | $26.82 | Direct | F1, F7 |
| transaction | ALKS | Employee Stock Option (Right to Buy) | Award | $0 | +274,328 | $0.000000 | 274,328 | 26 Feb 2024 | Ordinary Shares | 274,328 | $30.04 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5. |
| F2 | These options are fully vested in accordance with their terms. |
| F3 | Shares underlying the stock option award shall not vest and become exercisable unless and until the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, is fifty U.S. Dollars (US$50.00) or higher for thirty (30) consecutive trading days during the term of the award (the "performance criteria"). Subject to achievement of the performance criteria, the shares underlying the stock option award shall vest in four equal annual installments commencing on 2/21/2020. This award expires ten years from the date of grant. |
| F4 | Shares subject to the stock option award vest and become exercisable in four equal annual installments commencing on 2/20/2021. |
| F5 | Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. |
| F6 | Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023. |
| F7 | Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024. |
| F8 | Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025. |
EXHIBIT LIST: Exhibit 24.1 - Power of Attorney